The discovery could pave the way for new treatments, improved risk prediction, and earlier intervention for brain metastases.

The FDA-approved drug combination specifically targets low-grade serous ovarian cancer, which primarily affects younger women ...

University of Manchester researchers have shown that analysis of fluid flushed through a fallopian tube holds promise for ...

The decision to end the programme comes 18 months after Genmab's former partner for the acasunlimab, BioNTech, pulled out of ...

Genmab will stop development of its experimental antibody therapy to treat cancer that was in late-stage trials, the ‍Danish drugmaker said on Monday. The company had assumed sole responsibility for ...

Scientists at St. Jude Children's Research Hospital have revealed previously unappreciated roles for the retrotransposon LINE ...

Cancer cells survive therapy by dynamically rewiring their metabolism in response to nutrient availability, ...

Scientists at St. Jude Children's Research Hospital have revealed previously unappreciated roles for the retrotransposon LINE-1 in shaping the cancer genome structure and regulation.

Angus Chen covers all issues broadly related to cancer including drugs, policy, science, and equity. He joined STAT in 2021 after covering health and science at NPR and NPR affiliate stations. His ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. On the regional level, as the Human Development Index ...

Researchers at Baylor College of Medicine and collaborating institutions have uncovered new potential therapeutic targets for cancer and new insights into existing cancer drug targets, expanding the ...

Cancer begins with uncontrolled cell growth damaging organs. Six cancers, including lung, breast, and colorectal, lead global ...